160 Health International Limited (HKG:2656)

160 Health International Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	4,492	18,505	-	-	-
Enterprise Value	4,320	18,559	-	-	-
Last Close Price	13.35	55.00	-	-	-
PS Ratio	6.19	25.51	-	-	-
PB Ratio	17.24	71.03	-	-	-
P/TBV Ratio	16.98	69.97	-	-	-
EV/Sales Ratio	5.96	25.59	-	-	-
Debt / Equity Ratio	1.07	1.07	-1.24	-0.80	-0.09
Net Debt / Equity Ratio	-0.64	-0.64	-0.58	0.61	0.01
Net Debt / EBITDA Ratio	2.11	2.11	-0.51	0.26	0.04
Net Debt / FCF Ratio	1.26	1.26	-0.90	0.37	0.05
Asset Turnover	1.23	1.23	2.33	3.03	-
Inventory Turnover	11.74	11.74	74.71	42.09	-
Quick Ratio	1.17	1.17	0.63	0.70	0.19
Current Ratio	1.40	1.40	0.74	0.81	0.29
Return on Equity (ROE)	-102.37%	-102.37%	-	-	-
Return on Assets (ROA)	-8.65%	-8.65%	-24.57%	-29.74%	-
Return on Capital Employed (ROCE)	-30.10%	-30.10%	142.80%	578.20%	18.20%
Earnings Yield	-1.81%	-0.44%	-	-	-
FCF Yield	-2.94%	-0.71%	-	-	-
Buyback Yield / Dilution	-3.32%	-3.32%	-1.18%	-1.71%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error